WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: JUNE ISSUE PUBLISHED

    JUNE 2022 Issue has been successfully launched on 1 June 2022

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 June Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

DIASTOLIC DYSFUNCTION IN TYPE II DIABETES AND ITS CORRELATION WITH GLYCOSYLATED HAEMOGLOBIN

Tarfa Abed, MD*, Akram Jahjah, PHD and Munif Al Meri, PHD

ABSTRACT

Background: The alteration of left ventricular diastolic function is considered to be one of the earliest ultrasonographic signs of diabetic cardiomyopathy, which is a well-known chronic complication of diabetes mellitus. glycosylated haemoglobin (HBA1c) is the standard marker for monitoring the control of glycemic status, although biological studies indicate that HBA1c has a negative effect on the cardiovascular system, this effect has not been sufficiently studied so far. Aim: Highlight the role of HBA1c as not only a marker, but also a risk factor for diabetic cardiomyopathy. Materials and Methods: in this case-control study, a total of 80 patients with type2 diabetes aged between 40-70 years, were selected from Tishreen University Hospital and been included in the case group and been compared with 80 non diabetic participants as a control group, the two groups were matched in terms of: age, gender, blood pressure and BMI, the two groups were scrutinized for Doppler echocardiography, ECG, stress ecg, both groups underwent an objective exam, full biochemistry profile, and Blood pressure measurement. HBA1c analysis was performed for the case group. Results: in the case group Diastolic dysfunction of left ventricle was observed in 66 patients out of 80 (82.5%), the grades of Diastolic dysfunction were 33(50%) for grade I, 22(33.3%) for grade II, 11(16.7%) for grade III, 16(20%) patients of the case group had HBA1c <7,19(23.75%) with HBA1c between 7.1-8, 11(13.75%) with HBA1c between 8.1-9, 20(25%) with HBA1c >9, and 14(17.5%) without diastolic dysfunction all of them had HBA1c <7. in the control group Diastolic dysfunction of left ventricle was observed in 30 participants out of 80 (37.5%), the grades of Diastolic dysfunction grades were 28(93.3%) for grade I, 2 (6.7%) for grade II, 0% for grade III. Conclusion: Diastolic dysfunction of left ventricle is a common finding in patients with type 2 diabetes, elevated levels of HBA1c increase the risk of developing Diastolic dysfunction and with higher grades, Hence, it is a risk factor for diabetic cardiopathy.

[Full Text Article]